Prevalence of COPD in Our Lung Cancer Population, Compared to Controls
NCT ID: NCT02603627
Last Updated: 2015-11-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
200 participants
OBSERVATIONAL
2015-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
COPD Care Pathway Among Patients With Cancer
NCT05984680
Screening for Lung Cancer in Current or Past Smokers With Chronic Obstructive Pulmonary Disease
NCT00512746
Studying Patterns, Causes, and Control of Disease in Patients With Lung Cancer in the North Trent (England) Region
NCT00693836
Studies Examining the Importance of Smoking After Being Diagnosed With Lung Cancer
NCT01192256
An Observational Study of Predictors and Outcomes of Lung Cancer in Never-smokers in the UK
NCT06575439
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
COPD is diagnosed by testing lung function, usually using a small device called a spirometer.
COPD is becoming a better understood condition. It is known that the lungs of patients with COPD are sometimes inflamed. This is important because inflammation is associated with some types of cancer, including lung cancer.
The investigators are interested in whether COPD puts people at higher risk of lung cancer. They would like to find out how common COPD is in patients who have lung cancer. The investigators would also like to find out how common COPD is in patients who are not known to have lung cancer (comparison group). This will help them interpret their results better as investigators will be able to compare the two groups.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
ECOLOGIC_OR_COMMUNITY
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
With lung cancer
Patients who have a new diagnosis of lung cancer will be invited to undergo spirometry to enable us to gather data on the prevalence of COPD in this group.
No interventions assigned to this group
Without lung cancer
Smokers who are referred to the smoking cessation clinic will be invited to undergo spirometry to ascertain the prevalence of COPD in this group.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Aged over 18
* Lung cancer group: new diagnosis of lung cancer, with spirometry results available Control group: spirometry result available or obtained
Exclusion Criteria
* Age under 18
* Control group: pre-existing lung cancer
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Guy's and St Thomas' NHS Foundation Trust
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Tariq Sethi, MBBS PhD
Role: PRINCIPAL_INVESTIGATOR
King's Health Partners
Anthony Dorr, MBBS PhD
Role: PRINCIPAL_INVESTIGATOR
Guy's and St Thomas' NHS Foundation Trust
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Guy's and St Thomas' NHS Foundation Trust
London, England, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Tariq Sethi, MBBS PhD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
15/YH/0091
Identifier Type: OTHER
Identifier Source: secondary_id
RJ115/N106
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.